Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2018-10-17 2018-10-17
Drug Identification Number 02163705 02163705
Brand name ATROVENT NASAL SPRAY ATROVENT NASAL SPRAY
Common or Proper name ATROVENT Nasal Spray 0.03%, 345 doses - 21 mcg ATROVENT Nasal Spray 0.03%, 345 doses - 21 mcg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE
Strength(s) 21MCG 21MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration NASAL NASAL
Packaging size 30ml 30ml
ATC code R01AX R01AX
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-10-04 2018-10-04
Actual discontinuation date 2018-10-04 2018-10-04
Remaining supply date 2018-10-04 2018-10-04
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments